Agoracom Blog Home

Posts Tagged ‘health’

Where Beauty Meets Blockchain: How FTI Foodtech Is Revolutionizing the Industry with Game-Changing Innovations!

Posted by Paul Nanuwa at 10:20 AM on Tuesday, March 18th, 2025

Introduction:

Recent investigations have exposed the hazardous chemicals found in beauty products marketed toward Black women, including formaldehyde and lye in hair relaxers. Studies suggest that prolonged exposure to these chemicals can lead to increased health risks, including a 30% higher risk of breast cancer for frequent users of lye-based relaxers. These revelations highlight the urgent need for safe, non-toxic alternatives in the beauty industry.

FTI Foodtech International (TSXV: FTI) is stepping up to address this challenge. Through its beBlack cosmetics line and strategic acquisitions, FTI is pioneering clean beauty solutions that champion health, inclusivity, and innovation. By focusing on natural, non-toxic formulations, FTI is redefining the future of beauty for underrepresented communities.

Industry Outlook and FTI Foodtech’s Trajectory

The beauty industry is undergoing a fundamental transformation. Consumers are demanding transparency, sustainability, and safe, toxin-free products. Companies failing to adapt to this shift face increasing scrutiny.

FTI Foodtech is leading the way by positioning itself as a clean beauty innovator. The launch of beBlack Cosmetics, a premium line designed specifically for Black and melanated skin tones, demonstrates FTI’s commitment to providing safe, effective, and inclusive beauty solutions. This aligns with broader industry trends favoring natural ingredients, cruelty-free production, and advanced skincare technology.

Voices of Authority

Industry experts and advocacy groups have long warned about the disproportionate impact of hazardous beauty products on Black women. The lack of regulation and transparency in the cosmetics industry has fueled distrust among consumers.

The Guardian recently reported that many mass-market beauty products contain chemicals linked to hormone disruption, infertility, and even cancer. The rise of clean beauty is more than a trend—it’s a necessity.

By prioritizing scientifically-backed, non-toxic formulations, FTI Foodtech is setting a new standard for safe beauty products.

FTI Foodtech’s Key Initiatives in Clean Beauty

FTI Foodtech’s milestones highlight its rapid expansion and commitment to innovation in clean beauty:

beBlack Cosmetics: A high-performance, melanin-friendly cosmetics line featuring safe, toxin-free ingredients tailored to the unique needs of Black and darker skin tones.

Acquisition of Nayelle Skincare: A skincare brand renowned for its 100% natural probiotic process, enhancing skin nutrition and absorption without harmful additives.

Iluminate – Skincare in a Bottle: The first-ever skincare beverage, merging hydration and beauty benefits into one, launching in May 2025.

SmashFace Cryptocurrency & Cosmetics: A first-of-its-kind blockchain-powered beauty payment system designed to revolutionize consumer engagement and reward loyal customers.

Real-World Relevance: Why beBlack Matters

FTI Foodtech’s beBlack Cosmetics isn’t just another beauty brand—it’s a game-changer for underrepresented consumers. Here’s why it matters:

Safer Ingredients – No parabens, sulfates, or harmful additives found in many mainstream products.
Formulated for Melanin-Rich Skin – Custom formulations that cater to hyperpigmentation, hydration, and long-lasting wear.
Bridging the Beauty Gap – Many beauty brands still fail to represent or prioritize Black consumers—beBlack ensures that everyone is included.

The demand for safe and effective beauty solutions is at an all-time high, and FTI Foodtech is delivering.

Looking Ahead with FTI Foodtech

As the beauty industry evolves, FTI Foodtech is leading with purpose and innovation. The company is actively seeking distribution partnerships to bring Iluminate and beBlack Cosmetics to major retailers. With strategic acquisitions, blockchain integration, and market expansion, FTI is redefining the future of beauty and wellness.

Investors and consumers alike should take note—FTI Foodtech is not just keeping up with industry trends; it’s shaping them.

Conclusion: A Beauty Revolution with FTI Foodtech

The era of toxic beauty products is ending, and FTI Foodtech is at the forefront of the clean beauty movement. With beBlack Cosmetics, Iluminate, and SmashFace, the company is not just responding to consumer demand—it’s creating a safer, more inclusive beauty future.

For those seeking a brand that values health, innovation, and inclusivity—FTI Foodtech is the name to watch.


YOUR NEXT $FTI STEPS

$FTI HUB On AGORACOM: https://agoracom.com/ir/FTIFoodtechInternational
$FTI 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/FTIFoodtechInternational/profile
$FTI Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/FTIFoodtechInternational/forums/discussion

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit http://  https://agoracom.com/terms-and-conditions

Transforming Health and Safety with Innovative Partnerships and AI Technology

Posted by Brittany McNabb at 9:39 AM on Tuesday, March 5th, 2024

Introduction:

In today’s rapidly evolving world, the intersection of technology and healthcare has become increasingly crucial. Predictmedix stands at the forefront of this convergence, leveraging artificial intelligence to revolutionize health and safety protocols across various industries. Let’s delve into the company’s groundbreaking initiatives and transformative impact.

Background and Context:

Founded with a vision to enhance public health, Predictmedix AI has emerged as a leading provider of rapid health screening solutions powered by proprietary AI technology. With a focus on advancing health assessment methodologies, the company has garnered recognition for its innovative approach to promoting well-being.

Key Highlights and Partnerships:

  • Predictmedix’s strategic partnerships with industry leaders such as UVTV Digital India and KGK Science signify its commitment to innovation and collaboration.
  • Through alliances with UVTV Digital India, Predictmedix aims to revolutionize health and safety measures in sports and worship venues, promoting a culture of well-being across diverse communities.
  • The partnership with KGK Science underscores Predictmedix’s dedication to enhancing health research and product development, showcasing its ability to integrate AI technology into clinical trials for improved efficiency and accuracy.

Technological Advancements:

  • Leveraging AI algorithms, Predictmedix’s Safe Entry Stations offer rapid health screening capabilities, analyzing physiological data patterns to predict various health issues.
  • The company’s remote patient care platform empowers medical professionals with AI-powered tools to improve patient health outcomes, revolutionizing the healthcare landscape.

Potential Impact and Significance:

  • Predictmedix’s initiatives hold immense potential to transform public health and safety standards, offering innovative solutions for real-time health screening and monitoring.
  • By integrating AI technology into diverse settings such as sports arenas and religious institutions, Predictmedix aims to create safer environments and promote overall well-being.

Challenges and Considerations:

  • While Predictmedix’s advancements present promising opportunities, challenges such as regulatory compliance and technological integration may require careful navigation.

Conclusion:

In conclusion, Predictmedix’s pioneering efforts in leveraging AI for health and safety innovations position it as a key player in the healthcare technology landscape. With strategic partnerships, cutting-edge technology, and a commitment to improving public health, Predictmedix AI continues to lead the way towards a safer and healthier future.

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Predictmedix AI and KGK Science Forge a Health-Tech Nexus for Breakthrough Innovations

Posted by Brittany McNabb at 11:06 AM on Thursday, February 15th, 2024

Opening New Frontiers in Healthcare

The collaboration between Predictmedix AI and KGK Science signals a transformative shift in the healthcare landscape, promising innovative solutions to pressing challenges in health research and product development.

Enhancing Clinical Trials Efficiency

By integrating Predictmedix’s cutting-edge health assessment technologies with KGK Science’s clinical research expertise, the partnership aims to streamline participant screening, improve data collection accuracy, and introduce novel methods in continuous monitoring.

Setting New Standards for Health Product Innovation

With a shared commitment to excellence and innovation, Predictmedix AI and KGK Science are poised to redefine health product development, leveraging advanced technologies and regulatory expertise to drive meaningful advancements in healthcare solutions.

Leveraging Deep Industry Experience

KGK Science, with over two decades of experience in clinical research and regulatory consulting, brings invaluable insights and resources to the partnership, complementing Predictmedix AI’s innovative approach to health screening and remote patient care solutions.

Commitment to Excellence and Innovation

Rahul Kushwah, COO of Predictmedix AI, emphasizes the strategic importance of the collaboration, stating, “Our partnership with KGK Science is a testament to our shared vision for leveraging advanced health assessment technologies to open new avenues in health research and product development.”

A Vision for Future Healthcare

The alliance between Predictmedix AI and KGK Science represents a significant step towards improving health outcomes and operational efficiencies, signaling a commitment to excellence and innovation in the healthcare sector.

In summary, the partnership between Predictmedix AI and KGK Science holds immense potential to revolutionize healthcare research and product development, driving meaningful advancements and setting new standards for excellence in the industry.

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

 

VIDEO – PlantX Life Reports Record Revenue of Over $2M for April ‘21 $VEGA.ca $PLTXF $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 4:03 PM on Thursday, May 20th, 2021

The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.

PlantX Life (VEGA:CSE) (PLTXF:OTCQB) Is The One Stop Shop For Everything Plant Based + The  Digital Face of The Plant -Based Community More than just lip service, $VEGA reported RECORD revenues of  $2,042,450 for April 2021.

With a line up of plant based products and services that includes:

  • Plant Based Meal Delivery
  • Plant Based Snack Products
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
  • Plant Based Recipes
  • Plant Based Essentials …. Like Chocolate (Essential?  You Bet)
  • And …… Plant Based …. PLANTS (It’s A BIG Business!)

In addition, the company has:

If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX CEO Julia Frank.